Tomuzotuximab Usage And Synthesis

Uses

Tomuzotuximab (Anti-Human EGFR Recombinant Antibody) is a fully human glycoengineered IgG1 monoclonal antibody against EGFR. Tomuzotuximab has anticancer effects[1].

References

[1] Waer Fiedler, et al. Phase I study of tomuzotuximab, a glycoengineered therapeutic antibody against the epidermal growth factor receptor, in patients with advanced carcinomas. ESMO Open. 2018 Feb 1;3(2):e000303. DOI:10.1136/esmoopen-2017-000303

Tomuzotuximab(1646321-00-7)Related Product Information

• Lumiliximab
• Stamulumab
• Certolizumab
• Namilumab
• Bavituximab
• Fremanezumab
• Rovalpituzumab
• Tisotumab
• Efungumab
• Parsatuzumab